Conference · Tokyo, Japan
AsiaTIDES 2012
Pharmaceuticals · Biology
Key numbers
- Editions on record
- 6first in 2010
About AsiaTIDES
The only event in Asia with comprehensive updates on therapeutics in development from major big pharma, biotech and academic scientists worldwide
AsiaTIDES continues to be the premier forum to get a comprehensive update, meet key players and increase your knowledge of the oligonucleotide- and peptide-based therapeutics fields.
The faculty list for the 2012 program is the strongest yet, with more representation from big pharma than ever before. Hear new data and strategic perspectives from Merck, Genzyme, and GlaxoSmithKline, including three presentations from Glaxo on a peptide project and their assessments of both the oligo and peptide landscape. Plus hear from Isis, Novo Nordisk, Ipsen, Quark, Alnylam, Santaris, Tekmira and a host of other important companies you need to follow to stay abreast of this field.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2015 | 3–5 Mar 2015 | Hyatt Regency Osaka Osaka, Japan | — | — |
| 2014 | 25–27 Feb 2014 | Sheraton Miyako Hotel Tokyo, Japan | — | — |
| 2013 | 26–28 Feb 2013 | Sheraton Miyako Hotel Tokyo, Japan | — | — |
| 2012 | 28 Feb – 1 Mar 2012 | Sheraton Miyako Hotel Tokyo, Japan | — | — |
| 2011 | 2–4 Mar 2011 | Sheraton Miyako Hotel Tokyo, Japan | — | — |
| 2010 | 22–24 Feb 2010 | Sheraton Miyako Hotel Tokyo, Japan | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.